Skip header and navigation

Narrow By

5 records – page 1 of 1.

Cancer and the Risk of Blood Clots

https://libcat.nshealth.ca/en/permalink/chpams37420
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1675
Available Online
View Pamphlet
Cancer patients may be more at risk of developing blood clots, also called Cancer Associated Thrombosis or CAT. This pamphlet describes what blood clots are, those at highest risk, and what conditions may come from CAT. Terms used in the guide are explained.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Blood Coagulation Disorders
Neoplasms - complications
Subjects (LCSH)
Blood coagulation disorders
Cancer--Complications
Specialty
Hematology
Abstract
Cancer patients may be more at risk of developing blood clots, also called Cancer Associated Thrombosis or CAT. This pamphlet describes what blood clots are, those at highest risk, and what conditions may come from CAT. Terms used in the guide are explained.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1675
Less detail

The coagulation consult : a case-based guide

https://libcat.nshealth.ca/en/permalink/provcat33434
Alan Lichtin, John Bartholomew, editors. --New York: Springer , c2014.
Available Online
View e-Book
Location
Online
There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von…
Available Online
View e-Book
Other Authors
Lichtin, Alan
Bartholomew, John R
Responsibility
Alan Lichtin, John Bartholomew, editors
Place of Publication
New York
Publisher
Springer
Date of Publication
c2014
Physical Description
1 online resource (xii, 279 pages)
ISBN
9781461495604 (electronic bk.)
9781461495598
Subjects (MeSH)
Blood Coagulation Disorders - diagnosis
Blood Coagulation Disorders - therapy
Subjects (LCSH)
Blood coagulation disorders
Blood - Coagulation
Hematology
Oncology
Abstract
There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von Willebrand's disease. Newer antiplatelet agents are available and their use in patients receiving cardiac stents has mushroomed. The management of thrombosis in the setting of pregnancy has changed over the past decade, as well as the way clinicians approach women with multiple miscarriages. An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP). The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the field's most recent developments. This "case-directed" book describes state-of-the-art approaches to patients with bleeding and clotting disorders, as well as laboratory tests for coagulation. Chapters include different vignettes, focus on typical clinical consult questions, and lay out specific types of treatment. Practicing clinicians being confronted with a coagulation consult, students, residents, fellows and attending physicians will find this unique text an invaluable resource for some of the newer areas of coagulation science, therapy and pharmacology.
Contents
1. Laboratory Analysis of Coagulation -- 2. Easy Bruisability -- 3. Prolonged PT -- 4. Prolonged PTT -- 5. Prolongation of Both PT and aPTT -- 6. Excessive Bleeding with Normal Prothrombin Time, Partial Thromboplastin Time, and Platelet Count -- 7. Diagnosing Thrombocytopenia in the Clinic -- 8. Thrombocytopenia in the Intensive Care Unit and after Solid Organ Transplantation -- 9. Thrombocytosis -- 10. Prolonged Bleeding after Surgery -- 11. The Excessively Clotting Cancer Patient -- 12. Thrombotic Risk factors -- 13. Clotting around Catheters and Other Devices -- 14. Heparin-Induced Thrombocytopenia -- 15. Surgery on Patients on Antiplatelet Agents -- 16. Newer Oral Anticoagulants -- 17. Pregnancy.
Format
e-Book
Location
Online
Less detail

Consultative hemostasis and thrombosis

https://libcat.nshealth.ca/en/permalink/provcat32242
[edited by] Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle. (4th ed.) --Philadelphia, PA: Elsevier , c2019.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that’s new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors’ position that correct treatment begins with correct diagnosis.
Available Online
View e-Book
Other Authors
Kitchens, Craig S
Kessler, Craig M
Konkle, Barbara A
Responsibility
[edited by] Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle
Edition
4th ed.
Alternate Title
Consultative hemostasis & thrombosis
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
c2019
Physical Description
1 online resource, 872 p.
ISBN
9780323462020
Subjects (MeSH)
Blood Coagulation Disorders
Anticoagulants - therapeutic use
Blood Platelet Disorders
Fibrinolytic Agents - therapeutic use
Hemostasis - physiology
Thrombosis - pathology
Subjects (LCSH)
Blood coagulation disorders
Hemostasis
Blood Coagulation Disorders
Anticoagulants - therapeutic use
Blood Platelet Disorders
Fibrinolytic Agents - therapeutic use
Hemostasis - physiology
Thrombosis - pathology
Specialty
Hematology
Abstract
With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that’s new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors’ position that correct treatment begins with correct diagnosis.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Factor product pick-up

https://libcat.nshealth.ca/en/permalink/chpams35504
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Program, IWK Health Centre. Pediatric Bleeding Disorder Clinic. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
0928
Available Online
View Pamphlet
If you have a hereditary bleeding disorder and infuse factor products at home, this pamphlet will be given to you with instructions for when and where you can pick up products. Information on prescriptions and infusion records is also provided. Contact information for the QEII Adult Bleeding Disorder Clinic, IWK Pediatric Bleeding Disorder Clinic, and IWK/QEII Factor Product Utilization Assistant and MyCBDR Data Manager is listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Program
IWK Health Centre. Pediatric Bleeding Disorder Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
Blood Coagulation Disorders, Inherited
Hematologic Diseases
Subjects (LCSH)
Blood coagulation disorders
Specialty
Hematology
Abstract
If you have a hereditary bleeding disorder and infuse factor products at home, this pamphlet will be given to you with instructions for when and where you can pick up products. Information on prescriptions and infusion records is also provided. Contact information for the QEII Adult Bleeding Disorder Clinic, IWK Pediatric Bleeding Disorder Clinic, and IWK/QEII Factor Product Utilization Assistant and MyCBDR Data Manager is listed.
Responsibility
Prepared by: Nova Scotia Provincial Blood Coordinating Program, QEII Adult Bleeding Disorder Clinic and IWK Pediatric Bleeding Disorder Clinic
Pamphlet Number
0928
Less detail

Low Platelets : Thrombocytopenia

https://libcat.nshealth.ca/en/permalink/chpams37360
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
0032
Available Online
View Pamphlet
Platelets (PLT), thrombocytes, are blood cells that helps it to clot (stop bleeding). Not having enough platelets in your blood is called thrombocytopenia (throm·bo·cy·to·pe·nia). This pamphlets describes what causes low platelets, symptoms, and ways to prevent and manage it.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Antineoplastic Agents - adverse effects
Blood Coagulation Disorders
Drug-Related Side Effects and Adverse Reactions
Hematologic Diseases
Self Care
Thrombocytopenia
Subjects (LCSH)
Antineoplastic agents--Side effects
Blood cells--Diseases
Blood coagulation disorders
Cancer--Chemotherapy--Complications
Self-care, Health
Thrombocytopenia
Specialty
Hematology
Abstract
Platelets (PLT), thrombocytes, are blood cells that helps it to clot (stop bleeding). Not having enough platelets in your blood is called thrombocytopenia (throm·bo·cy·to·pe·nia). This pamphlets describes what causes low platelets, symptoms, and ways to prevent and manage it.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
0032
Less detail